Laboratory Abnormalities of Hepatic Encephalopathy

Area of Science:

• Hepatology
• Neurology
• Diagnostic Imaging

Background:

• Hepatic encephalopathy (HE) diagnosis lacks a gold standard, relying on clinical evaluation.
• Current imaging techniques like PET and MRI are not widely accessible or cost-effective for HE detection.
• Existing diagnostic methods for HE are often nonspecific.

Purpose of the Study:

• To review the current diagnostic landscape for hepatic encephalopathy.
• To explore the potential utility of electroencephalography (EEG) in diagnosing minimal HE.
• To identify gaps in current diagnostic capabilities for HE.

Main Methods:

• Literature review of diagnostic modalities for hepatic encephalopathy.
• Evaluation of the role of imaging techniques (PET, MRI) in HE detection.
• Assessment of electroencephalography (EEG) in conjunction with the Portal Systemic Hepatic Encephalopathy Score (PSHES).

Main Results:

• No definitive serologic or imaging biomarker currently exists for HE.
• PET and MRI show limited utility due to availability and cost.
• EEG, combined with PSHES, demonstrates potential for diagnosing minimal HE.

Conclusions:

• Hepatic encephalopathy diagnosis remains primarily clinical.
• Further research is needed to establish criteria, cutoffs, sensitivities, and specificities for EEG in HE diagnosis.
• Developing reliable diagnostic tools for HE is crucial for patient management.